Physician profile
Renee E Mason
NPI 1063404267
$38,212.42
in general payments reported to CMS, 2019-2025
35 companies · $1,870 in 2025
The $1,870 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,668 · 2020: $1,397 · 2021: $7,042 · 2022: $8,901 · 2023: $11K · 2024: $2,921 · 2025: $1,870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $13K · Education: $1,500 · Food and Beverage: $1,255 · Travel and Lodging: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,675.58 |
| Education | $1,500.00 |
| Food and Beverage | $1,254.96 |
| Travel and Lodging | $773.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $28,192.16 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $5,655.31 | 2019-2023 | Gardasil 9 |
| Intuitive Surgical, INC. | $2,343.28 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $331.91 | 2019-2024 | |
| Novo Nordisk INC | $206.97 | 2019-2025 | Wegovy |
| Smith+Nephew, INC. | $151.06 | 2022 | |
| Astellas Pharma US INC | $149.46 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $147.55 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $140.50 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $102.12 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $81.37 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $73.98 | 2022-2023 | |
| Shield Therapeutics INC | $66.44 | 2023-2025 | Accrufer |
| Therapeuticsmd, INC. | $65.51 | 2019-2022 | |
| Allergan, INC. | $61.67 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $58.13 | 2019-2022 | |
| Exeltis, USA INC. | $52.35 | 2023-2025 | Slynd |
| Hologic Sales and Service, LLC | $44.95 | 2019-2024 | Myosure Tissue Removal Device |
| Pacira Pharmaceuticals Incorporated | $41.05 | 2023 | Exparel |
| Myovant Sciences INC. | $23.13 | 2022 | |
| Lilly USA, LLC | $20.02 | 2025 | Zepbound |
| Dexcom, INC. | $19.75 | 2025 | Dexcom G6 Transmitter |
| Biogen, INC. | $19.04 | 2023 | |
| Daiichi Sankyo INC. | $17.98 | 2023 | Injectafer |
| Mylan Pharmaceuticals INC. | $16.88 | 2022 | |
| Avanos Medical | $14.24 | 2022 | |
| Exact Sciences Corporation | $14.11 | 2025 | Cologuard Collection Kit |
| Optumhealth Care Solutions, LLC | $13.48 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Agile Therapeutics, INC. | $13.35 | 2022 | |
| Avion Pharmaceuticals | $13.35 | 2022 | |
| Evofem Biosciences, INC. | $13.11 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.04 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.93 | 2019 | |
| Minerva Surgical, INC | $11.92 | 2019 | |
| Lupin INC. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.